Given the wide application of zinc oxide nanoparticles (ZnO NPs), the health hazards of these particles have attracted extensive worldwide attention. Many more studies on the biological interactions of ZnO NPs have been performed in recent years. In this study, we focused on the biological effects on BV2 microglial cells induced by ZnO NPs at non-or sub-toxic concentrations. We found that ZnO NPs at a concentration of 5 lg/ml could significantly activate cell proliferation, while ZnO NPs at other concentrations did not. We also found that ZnO NPs induced microglial cell activation in a timedependent manner. Moreover, a potent increase in the ratio of cells in S phase at all ZnO NPs concentrations was observed in a cell cycle analysis. Using inductively coupled plasma mass spectrometry (ICP-MS) and immunocytochemistry techniques, we demonstrated that ZnO dissolution could occur in the culture medium and in the lysosomes of BV2 cells. ZnO NPs significantly induced the phosphorylation of ERK and Akt, which might be involved in promoting cell proliferation.
. Umrani and Paknikar (2013) reported that ZnO NPs exhibited antidiabetic activity in diabetic rats after the oral administration of 1, 3, and 10 mg/kg; similar effects were observed in vitro (1, 3, and 10 mg/ml) (Asani et al., 2016) .
ZnO NPs had more potent toxic effects compared with other metallic oxide NPs such as titanium dioxide (TiO 2 ) Palomaki et al., 2010; Watson et al., 2014) , which were likely due to the ion-shedding ability of the ZnO NPs. ZnO NPs exhibited low solubility under neutral conditions, whereas these NPs are readily soluble under acidic conditions, such as those in lysosomes Jiang and Hsu-Kim, 2014) , which were similar with other soluble metallic nanoparticles such as silver (Comfort et al., 2014; Jiang et al., 2015) . Nevertheless, ZnO NPs showed significant higher solubility under acidic environment compared with silver NPs (Comfort et al., 2014; Donaldson et al., 2013; Jiang et al., 2015) . These ion-shedding properties imply that ZnO NPs might have celltype-dependent biological effects, particularly for cells such as macrophages containing numerous lysosomes (Zhang et al., 2012) or cancer cells with acidic microenvironments (Sasidharan et al., 2011) . Xia et al. (2008) indicated that ZnO NPs could dissolve in endosomes and culture medium; the non-dissolved ZnO NPs may enter the lysosomes within macrophages where the remaining NPs would be dissolved. In addition, numerous studies have shown that the positive effects induced by ZnO NPs at non-toxic concentrations might due to the zinc ions. Studies have reported that zinc is an antioxidant (Jomova and Valko, 2011; Prasad, 2009) and can reduce the levels of inflammatory cytokines (Prasad, 2009) . Moreover, zinc has also displayed significant procoagulation (Vu et al., 2013) and anti-diabetic effects (Bolkent et al., 2009) . Notably, these results were also observed in ZnO NPs studies, a finding which implies that these effects are most likely due to the zinc ions released from ZnO NPs.
Zinc is one of the most important essential elements for physiological metabolism and is necessary for many enzymes, including enzymes involved in the synthesis of DNA and RNA (Ryu et al., 2009) . Zinc is a critical requirement for cells to enter S phase (Beyersmann and Haase, 2001) . Moreover, zinc ions can activate numerous signaling pathways, such as the Akt and ERK pathways (Min et al., 2007; Rudolf and Cervinka, 2008; Ryu et al., 2009; Walter et al., 2006) , which are important for cell proliferation.
Microglia are resident macrophage-like cells in the central nervous system (CNS) (Wang et al., 2011) , and these cells are the first and most important immune defense for the CNS. Numerous studies have indicated that ZnO NPs can translocate into the brain through the blood brain barrier (Shrivastava et al., 2014) or through the olfactory-brain route (Kao et al., 2012) . Microglial cells release cytokines, modulate neuroinflammatory processes and play a very important role after the translocation of NPs into the brain. The results of Wang (Wang et al., 2011) indicated that Fe 2 O 3 NPs induce microglial proliferation, activation and recruitment in the brain after intranasal treatment.
Numerous studies have indicated that nanomaterials reduce the viability of cell lines at toxic concentrations (Xia et al., 2008; Zhang et al., 2012) , while notably, certain nanomaterials at low doses can induce cell proliferation (Asani et al., 2016; Kim et al., 2015; Rauch et al., 2012; Unfried et al., 2008; Zhang et al., 2014) . Numerous studies have been performed to address the toxicity of ZnO NPs; in contrast, little research has been conducted regarding the biological effects of ZnO NPs at non-or sub-toxic concentrations. BV2, an immortalized brain microglial cell line, has been frequently used to explore microglial cell properties in vitro (Wang et al., 2011) . In this study, we focus on the effects of non-or sub-toxic concentrations of ZnO NPs on BV2 cell proliferation and provide hypotheses regarding the probable mechanisms.
MATERIALS AND METHODS
Chemicals. ZnO NPs were purchased from Sigma (Sigma-Aldrich, USA, CAS Number 1314-13-2). ZnCl 2 was purchased from Sigma (Sigma-Aldrich, USA, CAS Number Z0152). Fetal bovine serum (FBS) and Dulbecco's modified Eagle's medium (DMEM) were purchased from Gibco (Thermo Fisher, USA). FluoZin-3 AM, LysoTracker Red DND-99 and Hoechst 33342 were purchased from Invitrogen (Thermo Fisher, USA). Iba-1 was purchased from Wako (Wako Chemicals, USA). ERK, p-ERK, Akt, and p-Akt were purchased from CST (CST, USA). NPs were dispersed by probe sonication for 120 min in PBS buffer to yield a stock solution of 1 mg/ml. All other reagents were of the highest purity commercially available and were used as received.
BV2 cell culture. The immortalized BV-2 microglial cell line was obtained from The Cell Bank of the Shanghai Infrastructure for Public Research and Development of the Chinese Academy of Medical Sciences. DMEM supplemented with 10% FBS and 1% penicillin/streptomycin (Gibco, USA) was used for the BV2 cell culture, and the cells were incubated at 37 C with 5% CO 2 in a 95% humidified atmosphere. The culture medium was replaced every other day, and the cells were passaged when the cell confluence reached 80-90%. To investigate the biological effects of ZnO NPs, BV2 cells were incubated in complete culture medium for 24 h before the addition of the ZnO NPs at various concentrations. ZnO NPs were diluted to 100 lg/ml from a stock solution of up to 1 mg/ml using PBS buffer, dispersed for 30 min with a sonicator to prevent aggregation, and then diluted to the specified concentrations (0, 5, 10, and 20 lg/ml) for treating the cells. ZnCl 2 was prepared using a stock solution of 12.3 mM. The ZnCl 2 solution was diluted to 12.3 lM, which was equivalent to a mass concentration of 0.8 lg/ml.
Cell proliferation assay. Cellular viability was determined using the CCK-8 assay (Dojindo, Japan). Cells were seeded with the same number of cells in each well of 96-well plates (5000 cells/ well). Next, 100 ll of complete culture medium was added per well, and the cells were incubated for 24 h at 37 C. ZnO NPs were then added to the 96-well plates at concentrations of 5, 10, 20, 40, 60, 80, and 100 lg/ml, and the plates were incubated for 3, 6, 12, or 24 h at 37 C. The control group was left untreated.
Finally, detection reagents were added to each well, and the 96-well plates were then incubated for an additional 2 h at 37 C. To prevent NPs from interfering in this analytical assay, an empty 96-well plate was prepared, and the solution in each well was quantitatively transferred. Subsequently, the absorbance was measured using a microplate reader at a wavelength of 450 nm. There were 6 replicates for each treatment.
Concentration of dissolved zinc in the cell culture medium. ZnO NPs suspensions (0, 5, 10, 20 , and 100 lg/ml) were prepared using complete culture medium and incubated for 24 h at 37 C. The suspensions were then centrifuged at 20 000 rpm for 30 min. The supernatants were transferred into 1.5-ml centrifuge tubes for analysis. The zinc content was detected with a Thermo X-Series 2 inductively coupled plasma mass spectrometry (ICP-MS) instrument (Thermo Fisher Scientific, USA).
Immunofluorescence microscopy to assess microglial activation. Prior to the experiment, we seeded cells on glass slides in 6-well plates. After a 12 h incubation leading to complete cell attachment, we replaced the culture medium with serum-free culture medium for cell starvation for 12 h. Then, we incubated the cells with the ZnO NPs (5 lg/ml) for 0, 6, 12, or 24 h and lipopolysaccharide (LPS) (100 ng/ml) for 24 h. After fixation with 4% paraformaldehyde, the slides were blocked for 1 h at 37 C with PBS buffer containing 5% bovine serum albumin and then incubated overnight with rabbit anti-iba-1 at 4 C in a humidified chamber.
Then, the slides were washed 3 times for 5 min each with PBS buffer. The slides were incubated with secondary antibody, DyLight 594-conjugated anti-rabbit IgG, for 1 h at 37 C under light-restricted conditions. Finally, the cell nuclei were loaded with Hoechst 33342 at 37 C for 20 min. All fluorescence measurements were obtained using an FV10i confocal microscope (Olympus, Japan).
Cell cycle analysis. Cell cycle analysis was performed by determining the DNA content in each cell using the Cell Cycle Detection Kit (Keygentech, China). First, cells were collected using 0.25% EDTA/trypsin and then washed twice with PBS buffer. Then, 70% ethanol was used to fix the cells at 4 C for 12 h.
Before staining with propidium iodide (PI), the cells were washed twice with PBS to remove the ethanol. Finally, the cells were incubated with 100 ll of RNAase for 30 min at 37 C. Then, 400 ll of PI was added to the cells, which were incubated at room temperature under light-restricted conditions for 30 min. Fluorescence values were analyzed on a BD FACSAria III (BD, USA), and the percentage of cells in each phase of the cell cycle (G0/G1, S and G2/M) was calculated using Modifit.
Transmission electron microscopy. For the transmission electron microscopy (TEM) examination, 2 Â 10 5 cells were incubated with
NPs for 24 h. Before cell collection, the cells were washed twice with PBS; the cells were then collected using cell scrapers and placed into 1.5-ml centrifuge tubes. The cells were centrifuged at 1000 rpm for 5 min, and the supernatant was discarded. The aggregated cells were fixed with 2.5% glutaraldehyde at room temperature for 1 h followed by 4 C for 3 h. The fixed cells were dehydrated through a graded ethanol series followed by acetone and then embedded. Ultrathin sections were prepared before observation with a Hitachi H-7500 TEM instrument (Hitachi, Japan).
Live cell fluorescence imaging and image analysis. BV2 cells were treated with 5 lg/ml ZnO NPs for 1, 6, or 12 h. After treatment, the cells were loaded with 3 lM FluoZin-3 at 37 C for 60 min.
The cells were then washed twice with PBS and incubated with culture medium at 37 C for 30 min to allow for complete penetration of the fluorescence probe. Then, the culture medium was removed, and the cells were loaded with 70 nM LysoTracker Red DND-99 at 37 C for 1 h. Finally, the cell nuclei were loaded with Hoechst 33342 at 37 C for 20 min. Before the observation of fluorescence, the cells were washed twice with PBS and sealed with anti-fade mounting medium (Beyotime, China). All the fluorescence measurements were obtained with an FV10i confocal microscope (Olympus, Japan).
Western blot analysis. After ZnO NPs treatment, cells were collected and washed twice with PBS, and then lysis buffer (KeyGEN, China) containing a protease inhibitor and phosphatase inhibitors was added on ice. The tubes were strongly vortexed for 30 s and then placed on ice for 5 min; this process was repeated 5 times. After centrifugation (30 min at 15 000 rpm, 4 C), the supernatant was transferred to another tube, and the protein concentration was determined using the BCA protein assay. An equal mass of protein (20 lg/well) was added to each lane, and 10% SDS-PAGE was conducted. Proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Merck Millipore, USA) and then washed with TBST [20 mM Tris-HCl, 500 mM NaCl (pH 7.5), and 0.01% Tween-20]. The membrane was blocked with TBST containing 5% skim milk for 1 h and then incubated overnight with primary antibodies directed against ERK (#4695), p-ERK (Thr202/Tyr204) (#4370), Akt (#4691), or p-Akt (Ser473) (#4060). The secondary antibody, IRDye 800CW-conjugated anti-rabbit IgG, was incubated with the membranes for 1 h at 37 C under light-restricted conditions.
Immunoreactive proteins were detected using the Odyssey infrared imaging system (Li-Cor, USA).
Statistical analysis. Results were represented as the means 6 SEM. All the data were statistically analyzed by an ANOVA. The homogeneity of variance test was performed, and the Bonferroni and Dunnett's T3 tests were used when equal variance was assumed and when there was no homogeneity, respectively. A P-value less than .05 was considered significant.
RESULTS

Characterization of ZnO NPs
The ZnO NPs used in this study had been characterized to some extent (particle size < 50 nm, surface area > 10.8 m 2 /g).
Meanwhile, prior to biological testing, we also detected the characterizations of ZnO NPs via TEM, scanning electron microscope (SEM), Dynamic light scattering (DLS), X-ray diffraction (XRD) ( Table 1 and Figure 1 ). The XRD analysis revealed that the ZnO NPs clearly exhibited a hexagonal structure ( Figure 1C ). The TEM data revealed the particle shapes and sizes. The ZnO NPs were rod shaped and small spheres, the average size were 26.4 6 2.3 nm (Table 1, Figure 1B ). The size detected via DLS was 242.5 nm, which indicated a strong agglomeration of the particles in water ( Figure 1D ). The zeta-potential of the ZnO NPs was 32.9 6 14.2 mV (Table 1) .
ZnO Induced BV2 Cell Proliferation
We assessed cell viability after treatment with ZnO NPs (5, 10, 20, 40, 60, 80 , and 100 lg/ml) ( Figure 2A ). The results showed that the ZnO NPs were nearly non-toxic at doses less than 20 lg/ml for 3, 6, and 12 h, whereas after treatment for 24 h, an obvious decrease in cell viability was observed at doses of 10 lg/ml (P < .01) and 20 lg/ml (P < .001). The doses above 40 lg/ml (including 40 lg/ml) showed potent decrease of cell viability after ZnO NPs treatment at 12 and 24 h (P < .001). Most notably, we observed a significant increase in cell number after 
Zinc Concentrations in Culture Medium with ZnO NPs
We studied the dissolution ability of ZnO NPs in complete culture media to assess the contribution to cellular toxicity of Zn ions dissolved in the culture medium. Zinc concentrations were determined via ICP-MS. We observed a significant concentration-dependent increase in the zinc concentration ( Figure 2B ). Moreover, we used 12lM ($0.8 lg/ml), which was close to the zinc concentration of the ZnO NPs (5 lg/ml) in culture medium, as the concentration of ZnCl 2 in this study. The data are summarized in Table 2 . 10, 20, 40, 60, 80 , and 100 mg/ml for 3, 6, 12, or 24 h, and then viability was determined using the CCK-8 method (A). ZnO NPs at concentrations of 0, 5, 10, 20, and 100 mg/ml were prepared in complete culture medium. The NPs were removed after high speed centrifugation, and the zinc ion concentrations were assessed via ICP-MS (B). The results represent the means 6 SEM from 3 independent experiments. *P < .05; **P < .01; ***P < .001, compared with control. ZnO NPs Induced BV2 Microglial Cell Activation We examined the stimulatory effects of ZnO NPs on BV2 cells, and we observed that ZnO NPs (5 lg/ml) could significantly induce BV2 cell activation in a time-dependent manner (Figure 3) . After a 24 h treatment, the ZnO NPs-induced BV2 cell activation status was similar to that of the LPS treatment group.
ZnO NPs Induced BV2 Cell Cycle Alterations
To provide more significant data to support the cell viability analysis, we detected cell cycles changes after treatment for 24 h with 0, 5, 10, or 20 lg/ml ZnO NPs or 12 lM ZnCl 2 . These data indicated that the number of cells in S phase was significantly increased in the ZnO NPs treatment groups compared with the control group, and the group treated with 5 lg/ml exhibited the highest S phase ratio ( Figure 4A and B) . Furthermore, we observed the morphological changes in the cells via TEM. We observed that the cells were generally normal in the control and 5 lg/ml groups, while we observed numerous cells undergoing mitosis (black arrow) in the 20 lg/ml group ( Figure 4C ).
Immunocytochemistry of Intracellular Zinc Ions and Lysosomes
We studied the status of intracellular zinc ions and lysosomes via immunocytochemistry ( Figure 5 ). We found that a significant amount of zinc ions could be observed in BV2 cells beginning at 1 h after treatment, and a slight increase in the zinc ion fluorescence values was observed after 6 h and 12 h of treatment. While, there was almost few zinc ions fluorescence values were observed in the control group. We also detected the lysosomal status via LysoTracker, a typical method to detect lysosomes. Our data revealed a significant overlap between zinc ions and lysosomes in BV2 cells.
ZnO NPs and Zinc Ions Induced Phosphorylation Levels Changes of Akt and ERK Pathways
We hypothesized that the ZnO NP-induced BV2 cell proliferation was due to the effects of zinc ions. We detected the phosphorylation levels of components in the ERK and Akt pathways, which are 2 key pathways that modulate cell proliferation. The western blot analysis data revealed significant changes in ERK and Akt phosphorylation. The phosphorylation levels of ERK also exhibited a significant increase in the 5 lg/ml group, which peaked at 1 h and then gradually decreased. For ZnO NPs at doses of 10 and 20 lg/ml, we also observed a slight increase in ERK phosphorylation levels after treatment, which were not significant when compared with the 5 lg/ml group (Figure 6 ). Meanwhile, we observed a significant increase in the level of Akt phosphorylation after treatment with 5 lg/ml ZnO NPs, beginning at 1 h and persisting at high levels until 24 h. For the 10 lg/ml and 20 lg/ml groups, no significant changes in Akt phosphorylation levels were observed compared with the control groups, only slight increase of Akt phosphorylation levels were observed at 1, 3 and 6h after 20 lg/ml ZnO NPs treatment ( Figure 7 ). Most notably, we assessed ERK and Akt phosphorylation levels after treatment with 12 lM ZnCl 2 . For ERK, we observed changes in the phosphorylation levels similar to those of the 5 lg/ml group; these levels peaked at 1 h and then decreased gradually to nearly basal levels at 24 h. For Akt, we detected a significant increase in the phosphorylation levels at 1 h similar to that of the 5 lg/ml group, although these levels decreased rapidly to basal levels.
DISCUSSION
The physicochemical properties of NPs are important for toxicological profiles, especially size and morphology. So many   FIG. 3 . Confocal microscopy to study ZnO NP-induced microglial cell activation. BV2 cells were treated with ZnO NPs (5 mg/ml) for 6, 12, or 24 h. The cells were immunohistochemically stained for iba-1 (red) and stained with Hoechst 33342 (blue). We observed a significant increase in red fluorescence in a time-dependent manner. Moreover, after 24 h of treatment, the BV2 cells exhibited activation effects similar to those observed with LPS (100 ng/ml) treatment.
studies have indicated that ZnO NPs induced toxicity with a size-dependent way due to the larger surface area and smaller NPs which can release more zinc ions and be taken up more readily by cells and tissues (Feltis et al., 2012; Roy et al., 2011; Sahu et al., 2014) . The variances of morphology also influence their toxicity under most conditions. The high aspect ratio particles, like nanotubes, nanowires, or nanorods, probably show more significant toxic effects. For example, rod-shaped ZnO NPs exhibited more significant toxicity than spherical ZnO NPs (Bhattacharya et al., 2014; Hsiao and Huang, 2011) . Nevertheless, Muller et al. (2010) attributed the ZnO NPs induced toxic effects to the intracellular released zinc ions, rather than high-aspect nature of ZnO nanowires, the rapid dissolution of ZnO might reduce the effect of the high aspect ratio in macrophages. For our study, the morphology induced variances probably were low because of the non-or sub-toxic dose and particles rapid dissolution happened in lysosomes. Some data have indicated that a high dose of ZnO NPs decreases cell viability due to multiple reasons, such as ROS, apoptosis, or autophagy (Buerki-Thurnherr et al., 2013; De Angelis et al., 2013; Johnson et al., 2015; Wahab et al., 2013) . Nevertheless, the effects of ZnO NPs at non-toxic doses are unclear. Notably, our data showed that ZnO NPs at 5 lg/ml induced a slight but significant increase in BV2 cell proliferation at the 6, 12, and 24 h time points, which is inconsistent with the data obtained at toxic doses. A slight decrease in cell viability with treatment at 10 and 20 lg/ml for 24 h was observed.
As evidenced via certain other studies and data obtained in this study, ZnO NPs can induce a significant decrease in cell viability at doses above 20 lg/ml for 12 or 24h (BuerkiThurnherr et al., 2013; Xia et al., 2008) .
Some studies have indicated that NPs can lead the recruitment of immune cells, such as macrophages (Arancibia et al., 2016) , eosinophils (Cho et al., 2012) , and microglial cells (Wang et al., 2011) , into targeted organs. Fe 2 O 3 NPs have been shown to induce microglial cell activation and phagocytosis (Wang et al., 2011) , and Babin et al. (2015) indicated that ZnO NPs enhance the phagocytic ability of neutrophils. Nevertheless, as the first defense of the CNS immune system, the immune response of microglia in the presence of ZnO NPs was unknown. In our study, we stained BV2 cells via iba-1, which is a microglia/macrophage cell marker. We found that ZnO NPs induced BV2 cell activation in a time-dependent manner. BV2 cells were partially activated as early as 6 h. After 24 h of treatment, the ZnO NPs exhibited activation effects similar to those observed in the LPS treatment group. These data showed that ZnO NPs might act as stimuli to activate intraneural immune response, however, the detailed molecular mechanism remains obscure.
Moreover, we also performed cell cycle analysis in this study. Although some other studies with high toxic concentrations have shown that cell cycle arrest at the S and G2/M phases occurs after ZnO NPs treatment (Guo da et al., 2015; Lai et al., 2015; Patel et al., 2016) , cell cycle data at non-toxic concentrations are rare. Our study obtained similar cell cycle results; we found that ZnO NPs induced increases in the number of cells in the S phase of the cell cycle in all groups. We hypothesized that ZnO NPs at 20 lg/ml could arrest the cells in S phase leading to the inhibitory effects on mitosis, while ZnO NPs at 5 lg/ml likely could not block mitosis. Conversely, the S-phase promoting effects probably accelerated cell cycle progression. Moreover, these ZnO NP-induced effects were evidenced by the TEM data, which showed that cells were in the mitotic phase primarily after 20 lg/ml ZnO NPs treatment for 24 h. In contrast, a normal distribution was noted for the control and 5 lg/ml groups. We hypothesized that 20 lg/ml ZnO NPs might disrupt the mitotic process due to a certain molecular mechanism, such as damage to the cytoskeletal system (Garcia-Hevia et al., 2016), which is important for mitosis.
Our study revealed that proliferation was significantly activated by 5 lg/ml ZnO NPs, whereas cell viability was reduced at concentrations of above 20 lg/ml. These contradictory results are not unusual. We considered that the ZnO NP-induced effects had a dual character: ZnO NPs induced toxic effects at high doses/concentrations but may exhibit some positive effects at low doses/concentrations. We indicated above that low doses of ZnO NPs could induce certain positive effects, which are likely due to the release of zinc ions from the NPs. Therefore, to reveal the mechanism of these contradictory results, we focused on the zinc ions.
Zinc is necessary for cell proliferation, particularly for the modulation of DNA synthesis and mitosis (Beyersmann and Haase, 2001; Ryu et al., 2009) . It is an important transition metal involved in numerous metabolic processes, such as the synthesis of enzymes. In addition, as evidenced in multiple studies, zinc also plays an important direct role in signal transduction and signaling functions. Sufficient data have indicated that zinc FIG. 5 . Confocal microscopy to study the cellular distribution of lysosomes and zinc ions in BV2 cells after ZnO NPs treatment. After BV2 cells treated with ZnO NPs (5 mg/ml) for 1, 6, or 12 h, the cells were loaded with FluoZin3 (green), LysoTracker (red) and Hoechst 33342(blue). We observed few zinc ions fluorescence in control group, while significant zinc ions (green) were observed as early as 1 h after ZnO NPs treatment, and a slight increase in the zinc fluorescence (green) was observed in a timedependent manner. Moreover, significant overlaps (yellow) between cellular zinc ions and lysosomes were observed at all time-points.
can promote cell proliferation (Cope et al., 2016; Emri et al., 2015; Rudolf and Cervinka, 2008) , whereas zinc deficiency impairs cell proliferation (Corniola et al., 2008) . Moreover, we attributed the ZnO NP-induced cell cycle-promoting effects to zinc ions because zinc ions increase the G1 to S phase transition rate (Ryu et al., 2009) .
We supposed that the zinc ions derived from ZnO NPs might play a key role in our experiments. In our study, we determined that the ZnO NPs could dissolve in culture medium in a dosedependent manner, and the non-dissolved NPs could penetrate into cells via endocytosis. These intracellular ZnO NPs that entered via endocytosis initially remained in lysosomes, which have an acidic environment. The dissolution process in lysosomes might be more potent for the macrophage-like microglial BV2 cells, which contain numerous lysosomes. We used the immunocytochemistry technique to detect intracellular zinc ions, and we observed that no zinc ions fluorescence was observed initially, while significant zinc ions fluorescences were detected early at 1 h after treatment. A study has indicated that NPs can be endocytosed as early as 30 min (Bourdenx et al., 2016) , which could provide sufficient time for ZnO NPs to release zinc ions. Moreover, using immunocytochemistry techniques, we demonstrated that zinc ions were released from ZnO NPs mainly in lysosomes based on the overlap between the lysosomes and zinc ions. We observed an increase in the zinc contents of lysosomes in a time-dependent manner, indicating a developing dissolution process in the microglial cells. These data indicated that ZnO NPs released zinc ions mainly in lysosomes as rapidly as possible, and the zinc ions in extracellular fluids might also participate in cytobiological effects. FIG. 6 . ERK phosphorylation levels after treatment with various doses of ZnO NPs. BV2 cells were treated with ZnO NPs at doses of 5, 10, or 20 mg/ml or ZnCl 2 at dose of 12 lM for 1, 3, 6, 12, or 24 h. The total protein was extracted, and the phosphorylation levels of ERK were analyzed via western blotting. The results represent the means 6 SEM from 3 independent experiments. *P < .05; **P < .01; ***P < .001, compared with control.
FIG. 7.
Akt phosphorylation levels after treatment with various doses of ZnO NPs. BV2 cells were treated with ZnO NPs at doses of 5, 10, or 20 mg/ml or ZnCl 2 at dose of 12 lM for 1, 3, 6, 12, or 24 h. Total protein was extracted, and Akt phosphorylation levels were analyzed via western blotting. The results represent the means 6 SEM from 3 independent experiments. *P < .05; **P < .01; ***P < .001, compared with control.
To define the detailed molecular mechanisms, we explored changes in 2 primary proliferation-related signaling pathways: ERK and Akt. Moreover, these 2 signaling pathways also play an important role in the progression of cells from the G1 to S phase of the cell cycle (Ryu et al., 2009) . As an important protein kinase of the mitogen-activated protein kinase (MAPK) cascades, ERK controls numerous cellular processes, including proliferation, differentiation, development, the stress response, and apoptosis (Rubinfeld and Seger, 2005) . ERK regulates the transmission of many mitogenic and oncogenic signals that result in the promotion of cell proliferation. ERK appears to be required for many cells to pass the G1 restriction point and to enter S phase. Akt, also known as protein kinase B or PKB, is activated via growth factors and other extracellular stimuli and then plays a key role in several biological effects, such as cell proliferation, survival and metabolism (Hers et al., 2011) . Akt also promotes cell cycle progression via the phosphorylation of glycogen synthase kinase-3, an Akt downstream substrate (Wei et al., 2005) .
Some studies have indicated that NPs, such as silica, gold, carbon and iron oxide, activate cell proliferation due to ERK (Kim et al., 2015; Rauch et al., 2012; Zhang et al., 2014) and/or Akt activation (Rauch et al., 2012; Unfried et al., 2008) . These activation effects occur very rapidly, even within minutes (Rauch et al., 2012) . In our study, we also observed similar activation results. We observed a potent increase in the level of ERK phosphorylation after treatment with 5 lg/ml ZnO NPs. ZnO NPs at doses of 10 and 20 lg/ml also induced ERK activation, but not as potently as that observed in the 5 lg/ml group. Moreover, zinc ions might play a crucial role in these NP-induced effects given that ZnCl 2 also exhibited similar results. When the cells were treated with ZnO NPs (5 lg/ml) or ZnCl 2 (12 lM), normal metabolism was not disturbed; as an important element in cellular metabolism, zinc ions activated ERK and stimulated cell proliferation. However, ZnO NPs at doses of 10 and 20 lg/ml, which are sub-toxic or toxic concentrations, probably slightly block the cascade effect within the cells and attenuate the ERK activation effects due to the generation of ROS (Piao et al., 2011) . Alternatively, ERK activation induced by toxic concentrations of NPs may be involved in cell apoptosis, as reported by another study (Sydlik et al., 2006) .
However, for the Akt signaling pathway, we observed a significantly sustained increase of the phosphorylation levels after ZnO NPs treatment at 5 lg/ml, whereas no potent increase was noted for the 10 and 20 lg/ml groups when compared with 5 lg/ml group. Moreover, we observed that zinc ions (12 lM) also stimulated Akt; the level of phosphorylated Akt transiently increased at 1 h and then declined rapidly to baseline. We hypothesized that 10 and 20 lg/ml ZnO NPs also disturbed normal cellular metabolism and induced ROS generation, which might disrupt the Akt cascade effects (Piao et al., 2011) . Zinc ions (12 lM) did not exhibit effects similar to ZnO NPs (5 lg/ml) most likely because the intracellular NPs remained in lysosomes and persistently released more zinc ions, which could activate the Akt pathway and sustain high levels.
Other studies on NPs in which NPs activated cell proliferation via the ERK and Akt pathways have indicated that NPs could likely activate EGF receptors that are required for the ERK and Akt signaling pathways. Alternatively, the NPs combined with a certain growth factor in the culture medium and then translocated into cells to activate related signaling pathways (Rauch et al., 2012; Unfried et al., 2008) . However, in our study using ZnO NPs, even we could not exclude the effects of NPs, we FIG. 8 . Schematic diagram of the ZnO NP-induced effects on BV2 microglial cell proliferation at non-toxic concentrations. ZnO NPs release zinc ions into the culture medium. The non-dissolved particles are endocytosed and dissolve in lysosomes due to the acidic environment. These zinc ions released from the ZnO NPs can regulate the cell cycle and activate the ERK and Akt signaling pathways, which ultimately promote cell proliferation.
attributed the proliferation effects primarily to the zinc ions. We discussed above that zinc salts activate the Akt (Min et al., 2007; Rudolf and Cervinka, 2008; Ryu et al., 2009; Walter et al., 2006) and ERK pathways (Rudolf and Cervinka, 2008; Ryu et al., 2009) , which are key signaling pathways for cell proliferation, in various cell types. The results of Emil (Rudolf and Cervinka, 2008) indicated that zinc ions induced cell proliferation via certain key signaling pathways, such as Akt and MAPK. Ryu et al. (2009) also observed the same results. Moreover, zinc ioninduced cell cycle alterations can probably be attributed to the Akt and MAPK signaling pathways (Ryu et al., 2009; Wei et al., 2005) . We hypothesized that 5 lg/ml was too low a dose to provide sufficient NPs to play a main role in promoting cell proliferation, besides, the dissolution process also attenuated the particles' effects. Moreover, in addition to the extracellular zinc ions released into the culture medium, the initial levels of intracellular NPs present in lysosomes and the potent and persistent release of zinc ions likely served as key factors.
CONCLUSION
In summary, the data are illustrated in Figure 8 and demonstrate that ZnO NPs at non-toxic concentrations can release zinc ions into the culture medium and lysosomes, which induce BV2 cell proliferation via the Akt and ERK signaling pathways. Moreover, ZnO NPs can accelerate the progression of the cell cycle from the G1 to S phase, which also might promote cell proliferation. The findings from this study provide new insights into the effects of NPs at non-toxic concentrations, particularly for soluble NPs such as ZnO, which will provide new potential applications for nanomaterials and information for nanotoxicology.
